Adel Malek MD PhD retweeted
🚨 Study Approved in Canada!
STRIDE trial is launching to study the eShunt System — an endovascular alternative to VP shunts for normal pressure hydrocephalus (NPH).
👥 Now enrolling potential candidates
📩 [email protected]
@RADIS_lab @SmhNeuroVasc @StMichaelsFdn
Health Canada has authorized STRIDE trial for NPH treatment with the minimally invasive CereVasc eShunt® System—now enrolling in 🇨🇦🇺🇸🇦🇷. We’re proud to advance care in neuroscience.
Learn more 👉 nphstridestudy.com
#CereVasc #eShunt #NPH #STRIDETrial #NeuroInnovation
Congrats to the amazing team at @CereVasc on FDA Breakthrough Device Designation for the #eShunt in pediatric patients over 12 years of age with communicating #hydrocephalus—a big step toward less invasive care for children.
🔗 [prnewswire.com/news-releases…]
#neurosurgery #FDA #MedTech
Adel Malek MD PhD retweeted
#STROKE: In a secondary analysis of the PACIFIC-STROKE trial, the presence of hemorrhagic infarction was not associated with worse functional outcomes. @PoojaKhatriMD @VCI_EricSmith @HanneKChr @gmdemarchis @Antonyneuro @Ash_Shoamanesh #AHAJournals ahajrnls.org/42lj2Yf
Adel Malek MD PhD retweeted
New study shows endovascular thrombectomy (EVT) is safe and effective for acute ischemic stroke patients with pre-existing disability—a group often excluded from trials -- with good odds of returning to baseline at 90 days post-EVT. bit.ly/4iXA18x #Stroke #Neurointervention #Thrombectomy
Adel Malek MD PhD retweeted
Do your patients experience shuffling feet, cognitive impairment, or incontinence? These symptoms may be normal pressure #hydrocephalus and may prequalify your patients for the STRIDE #clinicaltrial—evaluating the #endovascular eShunt® system.
Learn more: STRIDEclinicaltrial.com
Adel Malek MD PhD retweeted
.@CereVasc has reported initial results from its pilot @US_FDA-approved IDE clinical study of the eShunt system in the treatment of elderly patients with normal-pressure hydrocephalus
@CharlesMatouk @MatoukCharles
neuronewsinternational.com/c…
Adel Malek MD PhD retweeted
Team @Monte_NIS enrolled another patient in the @cerevasc pilot trial for the E-shunt, an endovascular treatment for NPH 🧠💦
🙏🏻🙏🏻🙏🏻 @circleowillis
@MontefioreRAD @MonteNeurosg @NeuroMonteEinst @MontefioreNYC – at Bronx, NY
Adel Malek MD PhD retweeted
Saw my first e-shunt today with @amandaebaker!! Thanks @MatoukCharles @YaleMed @CereVasc Amazing technology!
Adel Malek MD PhD retweeted
After all those words, I’m at a loss for words. All I can say is thank you to everyone who has inspired and supported me on this path.
#2023CNS #IMAGINE #INNOVATE #INSPIRE – at Washington, DC
This morning, #2023CNS President, @EladLevyMD, gave a powerful & inspirational Presidential Address to the largest group of @CNS_Update Annual Meeting attendees in CNS history! 👏
#UBNSxCNS #neurosurgery #neurotwitter
Adel Malek MD PhD retweeted
Cerebral veins: a new frontier in Neuro-IR.
sciencedirect.com/science/ar…
@NguyenThanhMD @ferdinandhui @MattAmansMD @eytanraz @uta_hanning @alicenomalice @WBrinjikji @adelmalek @tomoxl @BDouraied @JNeuroradiology
Adel Malek MD PhD retweeted
Do you remember our seventh Annual Meeting in Carlsbad, California? 🌊
You can look through photos from past meetings using our Flickr: flickr.com/photos/197952936@…
Make sure to register for our 20th Annual Meeting July 21-August 4! ➡️pulse.ly/219uxv9ax1
Adel Malek MD PhD retweeted
Very glad to be part of this amazing project!
JNIS Latest Content
@eneri_neuro et al describe first-in-human endovascular transdural CSF shunt using the @CereVasc system #medtwitter #neurotwitter #hydrocephalus
@adelmalek @hydrocephalusso
bit.ly/3lAuyJo
Adel Malek MD PhD retweeted
Just Published bit.ly/3lAuyJo & just in ⌛️ for @brainconferenc1. The 1⃣ & ONLY Prof. Lylyk from the fabulous @ENERI_BSAS presenting the cutting edge E-Shunt @adelmalek @CereVasc @HydroAssoc @hydrocephalusso
@theBSNR @_the_SRT @esmintsociety @PairsNeuro @svinsociety
Adel Malek MD PhD retweeted
The eShunt System, co-invented at #TuftsMC by Neurosurgeon-in-Chief Dr. Carl Heilman & Chief of Neurovascular Surgery Dr. @adelmalek is being developed by @CereVasc as the first-ever minimally-invasive treatment for communicating hydrocephalus. bit.ly/3oCcUXL
Grateful to all my colleagues and friends for making this first step possible @CereVasc @eneri_neuro @TuftsNeurosurg @TuftsMedicalCtr
First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt jnis.bmj.com/content/early/2…
Adel Malek MD PhD retweeted
Happy to see this work from my research experience at @adelmalek's lab being published @TheJNS! Check it out!
@cvsection @MemphisNSGY
@TuftsNeurosurg
thejns.org/view/journals/j-n…



































